But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...

Cancer care in 2026 now relies on immunotherapy, targeted therapy, and multimodality treatment, even in early stages, ...

As a full-time practicing medical oncologist in Winchester, I spend my days with Virginians who bravely fight cancer. Sadly, ...

Mumbai: A new study from the Tata Memorial Centre has highlighted that many modern cancer medicines, especially immunotherapy ...

Check out some of the companies making the biggest midday moves: Oil stocks — Oil stocks briefly traded higher as the ...

Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide — brand name Revlimid — to treat it. She has not been able to fill that prescription in more than two ...

All 16 of the drug manufacturers that signed deals with Trump have issued price hikes this year, according to reports.

Some drug pricing reforms will leave independent practitioners under water, argue guest columnists Madelaine Feldman and ...

Prices of common drugs for cancer, multiple sclerosis and other conditions can vary widely depending on the hospital where they're administered, research firm 3 Axis Advisors said in a new report. Why ...

DONALD TRUMP SPOKE ABOUT prescription drugs for more than three minutes during Tuesday night’s State of the Union address. That’s practically an eternity, given the context and setting. But it’s not ...

U.S. Rep. Jodey Arrington's bills, including one for early cancer detection and another to lower drug costs by regulating ...

Voluntary MFN commitments by 16 manufacturers reportedly cover ~70% of Medicare drug spending, potentially obviating GUARD/GLOBE finalization while avoiding predictable legal challenges. Lindsay ...